Cargando…

Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection

Cutaneous eruption is a common drug-adverse reaction, characterised by keratinocytes inflammation and apoptosis. Shuanghuanglian injeciton (SHLI) is a typical Chinese medicine injection, which is used to treat influenza. It has been reported that SHLI has the potential to induce cutaneous adverse er...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yidan, Zhang, Xiujun, Fan, Shanshan, Song, Lili, Yang, Zhen, Zhuang, Pengwei, Zhang, Yanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099613/
https://www.ncbi.nlm.nih.gov/pubmed/29921748
http://dx.doi.org/10.3390/molecules23061477
_version_ 1783348705908228096
author Zhang, Yidan
Zhang, Xiujun
Fan, Shanshan
Song, Lili
Yang, Zhen
Zhuang, Pengwei
Zhang, Yanjun
author_facet Zhang, Yidan
Zhang, Xiujun
Fan, Shanshan
Song, Lili
Yang, Zhen
Zhuang, Pengwei
Zhang, Yanjun
author_sort Zhang, Yidan
collection PubMed
description Cutaneous eruption is a common drug-adverse reaction, characterised by keratinocytes inflammation and apoptosis. Shuanghuanglian injeciton (SHLI) is a typical Chinese medicine injection, which is used to treat influenza. It has been reported that SHLI has the potential to induce cutaneous adverse eruptions. However, the mechanisms remain unclear. Since desmoglein 1 (DSG1) shows a crucial role in maintaining skin barrier function and cell susceptibility, we assume that DSG1 plays a critical role in the cutaneous eruptions induced by SHLI. In our study, retinoic acid (RA) was selected to downregulate the DSG1 expression, and lipopolysaccharide (LPS) was first used to identify the susceptibility of the DSG1-deficiency Hacat cells. Then, SHLI was administrated to normal or DSG1-deficient Hacat cells and mice. The inflammatory factors and apoptosis rate were evaluated by RT-PCR and flow cytometry. The skin pathological morphology was observed by hematoxylin and eosin (HE) staining. Our results show that treated only with SHLI could not cause IL-4 and TNF-α mRNA increases in normal Hacat cells. However, in the DSG1-deficient Hacat cells or mice, SHLI induced an extreme increase of IL-4 and TNF-α mRNA levels, as well as in the apoptosis rate. The skin tissue showed a local inflammatory cell infiltration when treated with SHIL in the DSG1-deficient mice. Thus, we concluded that DSG1 deficiency was a potential causation of SHLI induced eruptions. These results indicated that keratinocytes with DSG1 deficiency were likely to induce the cutaneous eruptions when stimulated with other medicines.
format Online
Article
Text
id pubmed-6099613
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60996132018-11-13 Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection Zhang, Yidan Zhang, Xiujun Fan, Shanshan Song, Lili Yang, Zhen Zhuang, Pengwei Zhang, Yanjun Molecules Article Cutaneous eruption is a common drug-adverse reaction, characterised by keratinocytes inflammation and apoptosis. Shuanghuanglian injeciton (SHLI) is a typical Chinese medicine injection, which is used to treat influenza. It has been reported that SHLI has the potential to induce cutaneous adverse eruptions. However, the mechanisms remain unclear. Since desmoglein 1 (DSG1) shows a crucial role in maintaining skin barrier function and cell susceptibility, we assume that DSG1 plays a critical role in the cutaneous eruptions induced by SHLI. In our study, retinoic acid (RA) was selected to downregulate the DSG1 expression, and lipopolysaccharide (LPS) was first used to identify the susceptibility of the DSG1-deficiency Hacat cells. Then, SHLI was administrated to normal or DSG1-deficient Hacat cells and mice. The inflammatory factors and apoptosis rate were evaluated by RT-PCR and flow cytometry. The skin pathological morphology was observed by hematoxylin and eosin (HE) staining. Our results show that treated only with SHLI could not cause IL-4 and TNF-α mRNA increases in normal Hacat cells. However, in the DSG1-deficient Hacat cells or mice, SHLI induced an extreme increase of IL-4 and TNF-α mRNA levels, as well as in the apoptosis rate. The skin tissue showed a local inflammatory cell infiltration when treated with SHIL in the DSG1-deficient mice. Thus, we concluded that DSG1 deficiency was a potential causation of SHLI induced eruptions. These results indicated that keratinocytes with DSG1 deficiency were likely to induce the cutaneous eruptions when stimulated with other medicines. MDPI 2018-06-19 /pmc/articles/PMC6099613/ /pubmed/29921748 http://dx.doi.org/10.3390/molecules23061477 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Yidan
Zhang, Xiujun
Fan, Shanshan
Song, Lili
Yang, Zhen
Zhuang, Pengwei
Zhang, Yanjun
Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title_full Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title_fullStr Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title_full_unstemmed Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title_short Desmoglein1 Deficiency Is a Potential Cause of Cutaneous Eruptions Induced by Shuanghuanglian Injection
title_sort desmoglein1 deficiency is a potential cause of cutaneous eruptions induced by shuanghuanglian injection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099613/
https://www.ncbi.nlm.nih.gov/pubmed/29921748
http://dx.doi.org/10.3390/molecules23061477
work_keys_str_mv AT zhangyidan desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT zhangxiujun desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT fanshanshan desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT songlili desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT yangzhen desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT zhuangpengwei desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection
AT zhangyanjun desmoglein1deficiencyisapotentialcauseofcutaneouseruptionsinducedbyshuanghuanglianinjection